These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 28258421)

  • 1. Phenomapping for the Identification of Hypertensive Patients with the Myocardial Substrate for Heart Failure with Preserved Ejection Fraction.
    Katz DH; Deo RC; Aguilar FG; Selvaraj S; Martinez EE; Beussink-Nelson L; Kim KA; Peng J; Irvin MR; Tiwari H; Rao DC; Arnett DK; Shah SJ
    J Cardiovasc Transl Res; 2017 Jun; 10(3):275-284. PubMed ID: 28258421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenomapping for novel classification of heart failure with preserved ejection fraction.
    Shah SJ; Katz DH; Selvaraj S; Burke MA; Yancy CW; Gheorghiade M; Bonow RO; Huang CC; Deo RC
    Circulation; 2015 Jan; 131(3):269-79. PubMed ID: 25398313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenomapping of patients with heart failure with preserved ejection fraction using machine learning-based unsupervised cluster analysis.
    Segar MW; Patel KV; Ayers C; Basit M; Tang WHW; Willett D; Berry J; Grodin JL; Pandey A
    Eur J Heart Fail; 2020 Jan; 22(1):148-158. PubMed ID: 31637815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in Repolarization Heterogeneity Among Heart Failure With Preserved Ejection Fraction Phenotypic Subgroups.
    Oskouie SK; Prenner SB; Shah SJ; Sauer AJ
    Am J Cardiol; 2017 Aug; 120(4):601-606. PubMed ID: 28651852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and prognostic implications of phenomapping in patients with heart failure receiving cardiac resynchronization therapy.
    Riolet C; Menet A; Verdun S; Altes A; Appert L; Guyomar Y; Delelis F; Ennezat PV; Guerbaai RA; Graux P; Tribouilloy C; Marechaux S
    Arch Cardiovasc Dis; 2021 Mar; 114(3):197-210. PubMed ID: 33431324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Echocardiographic and Cardiac Magnetic Resonance Evaluation Differentiates Among Heart Failure With Preserved Ejection Fraction Patients, Hypertensive Patients, and Healthy Control Subjects.
    Mordi IR; Singh S; Rudd A; Srinivasan J; Frenneaux M; Tzemos N; Dawson DK
    JACC Cardiovasc Imaging; 2018 Apr; 11(4):577-585. PubMed ID: 28823736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in Cardiac Mechanics and Exercise Physiology Among Heart Failure With Preserved Ejection Fraction Phenomapping Subgroups.
    Dixon DD; Beussink-Nelson L; Deo R; Shah SJ
    Am J Cardiol; 2023 Apr; 193():102-110. PubMed ID: 36893548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and design of the PACIFIC-PRESERVED (PhenomApping, ClassIFication and Innovation for Cardiac dysfunction in patients with heart failure and PRESERVED left ventricular ejection fraction) study.
    Hulot JS; Janiak P; Boutinaud P; Boutouyrie P; Chézalviel-Guilbert F; Christophe JJ; Cohen A; Damy T; Djadi-Prat J; Firat H; Hervé PY; Isnard R; Jondeau G; Mousseaux E; Pernot M; Prot P; Tyl B; Soulat G; Logeart D;
    Arch Cardiovasc Dis; 2024 May; 117(5):332-342. PubMed ID: 38644067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the role of left atrial strain using two-dimensional speckle tracking echocardiography in patients with diabetes mellitus and heart failure with preserved left ventricular ejection fraction.
    Georgievska-Ismail L; Zafirovska P; Hristovski Z
    Diab Vasc Dis Res; 2016 Nov; 13(6):384-394. PubMed ID: 27407084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart failure with preserved ejection fraction phenogroup classification using machine learning.
    Kyodo A; Kanaoka K; Keshi A; Nogi M; Nogi K; Ishihara S; Kamon D; Hashimoto Y; Nakada Y; Ueda T; Seno A; Nishida T; Onoue K; Soeda T; Kawakami R; Watanabe M; Nagai T; Anzai T; Saito Y
    ESC Heart Fail; 2023 Jun; 10(3):2019-2030. PubMed ID: 37051638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Utility and Clinical Significance of Cardiac Mechanics in Heart Failure With Preserved Ejection Fraction: Importance of Left Atrial Strain.
    Freed BH; Daruwalla V; Cheng JY; Aguilar FG; Beussink L; Choi A; Klein DA; Dixon D; Baldridge A; Rasmussen-Torvik LJ; Maganti K; Shah SJ
    Circ Cardiovasc Imaging; 2016 Mar; 9(3):. PubMed ID: 26941415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel pheno-groups in heart failure with preserved ejection fraction using machine learning.
    Hedman ÅK; Hage C; Sharma A; Brosnan MJ; Buckbinder L; Gan LM; Shah SJ; Linde CM; Donal E; Daubert JC; Mälarstig A; Ziemek D; Lund L
    Heart; 2020 Mar; 106(5):342-349. PubMed ID: 31911501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac mechanics in mild hypertensive heart disease: a speckle-strain imaging study.
    Narayanan A; Aurigemma GP; Chinali M; Hill JC; Meyer TE; Tighe DA
    Circ Cardiovasc Imaging; 2009 Sep; 2(5):382-90. PubMed ID: 19808626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incremental diagnostic value of la strain with leg lifts in heart failure with preserved ejection fraction.
    Obokata M; Negishi K; Kurosawa K; Arima H; Tateno R; Ui G; Tange S; Arai M; Kurabayashi M
    JACC Cardiovasc Imaging; 2013 Jul; 6(7):749-58. PubMed ID: 23747067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combined exercise stress echocardiography and cardiopulmonary exercise test for identification of masked heart failure with preserved ejection fraction in patients with hypertension.
    Nedeljkovic I; Banovic M; Stepanovic J; Giga V; Djordjevic-Dikic A; Trifunovic D; Nedeljkovic M; Petrovic M; Dobric M; Dikic N; Zlatar M; Beleslin B
    Eur J Prev Cardiol; 2016 Jan; 23(1):71-7. PubMed ID: 26358991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Area strain from 3D speckle-tracking echocardiography as an independent predictor of early symptoms or ventricular dysfunction in asymptomatic severe mitral regurgitation with preserved ejection fraction.
    Casas-Rojo E; Fernández-Golfin C; Moya-Mur JL; González-Gómez A; García-Martín A; Morán-Fernández L; Rodríguez-Muñoz D; Jiménez-Nacher JJ; Martí Sánchez D; Zamorano Gómez JL
    Int J Cardiovasc Imaging; 2016 Aug; 32(8):1189-98. PubMed ID: 27161336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenomapping Heart Failure with Preserved Ejection Fraction Using Machine Learning Cluster Analysis: Prognostic and Therapeutic Implications.
    Galli E; Bourg C; Kosmala W; Oger E; Donal E
    Heart Fail Clin; 2021 Jul; 17(3):499-518. PubMed ID: 34051979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of chronic kidney disease with abnormal cardiac mechanics and adverse outcomes in patients with heart failure and preserved ejection fraction.
    Unger ED; Dubin RF; Deo R; Daruwalla V; Friedman JL; Medina C; Beussink L; Freed BH; Shah SJ
    Eur J Heart Fail; 2016 Jan; 18(1):103-12. PubMed ID: 26635076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Left Ventricular Relaxation and Left Atrial Function in Patients With Heart Failure and Preserved Ejection Fraction Versus Patients With Systemic Hypertension and Healthy Subjects.
    Okura H; Kataoka T; Yoshida K
    Am J Cardiol; 2016 Oct; 118(7):1019-23. PubMed ID: 27515892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired myocardial oxygen availability contributes to abnormal exercise hemodynamics in heart failure with preserved ejection fraction.
    van Empel VP; Mariani J; Borlaug BA; Kaye DM
    J Am Heart Assoc; 2014 Dec; 3(6):e001293. PubMed ID: 25468660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.